Taxanos en el tratamiento adyuvante del cáncer de mama con ganglios positivos: metanálisis

Chemotherapy regimens including a taxane in the adjuvant therapy setting for breast cancer with positive nodes provide a significant improvement regarding increased diseasefree survival and overall survival at 5 years.